Connection
Mary Weiser-Evans to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Mary Weiser-Evans has written about Drug Evaluation, Preclinical.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.019 |
|
|
|
-
Nemenoff R, Meyer AM, Hudish TM, Mozer AB, Snee A, Narumiya S, Stearman RS, Winn RA, Weiser-Evans M, Geraci MW, Keith RL. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma. Cancer Prev Res (Phila). 2008 Oct; 1(5):349-56.
Score: 0.019